Suppliers / Corden Pharma Colorado

Corden Pharma Colorado

United States Updated 9 July 2026

The public registers hold a second record for Corden Pharma Colorado. The fuller profile, with 17 active US DMFs and 3 valid CEPs, is at Corden Pharma. Figures on this page cover only this record.

Corden Pharma Colorado is an API manufacturer based in United States. It holds 2 active US drug master files across a filed portfolio of 4 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Linaclotide SFDA (Saudi Arabia), US FDA 2
Ganciclovir SFDA (Saudi Arabia) 1
Tirzepatide SFDA (Saudi Arabia) 1
Valganciclovir US FDA 1

Also appears on these molecule pages

Questions about Corden Pharma Colorado

Does Corden Pharma Colorado hold a US DMF or a CEP?
Corden Pharma Colorado holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Corden Pharma Colorado make?
4 molecules are on record against Corden Pharma Colorado, including Linaclotide, Ganciclovir, Tirzepatide and Valganciclovir. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Corden Pharma Colorado comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability